摘要
英夫利西单抗有助于防止克罗恩病的复发,是克罗恩病合并短肠综合征者的有效治疗手段,有助于防止剩余小肠受累,提高生活质量。
Infliximah is an effective therapy in patients with Crohn' s disease affiliated short-bowel syndrome, which could induce remission of Crohn' s disease, prevent the remaining small bowel involvement and improve the quality of life.
出处
《胃肠病学和肝病学杂志》
CAS
2009年第9期809-809,813,共2页
Chinese Journal of Gastroenterology and Hepatology